Pfizer Limited (NSE: PFIZER)

Pfizer Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	1,120	366	627.6	1,570	17,638
Short-Term Investments	-	19,153	18,118	15,705	9,494	4,310
Cash & Short-Term Investments	20,467	20,273	18,484	16,332	11,064	21,948
Cash Growth	10.73%	9.68%	13.17%	47.61%	-49.59%	16.02%
Accounts Receivable	-	1,876	1,517	1,426	1,088	1,720
Other Receivables	-	514.4	403.4	874.6	1,909	1,551
Receivables	-	2,391	1,921	2,303	2,998	3,307
Inventory	-	4,337	4,177	4,489	4,351	4,306
Prepaid Expenses	-	80.1	70.4	72.8	50.7	96.2
Restricted Cash	-	45.9	39	74.8	16.5	-
Other Current Assets	-	569.5	560.2	342.7	604.7	825.6
Total Current Assets	-	27,696	25,251	23,614	19,085	30,483
Property, Plant & Equipment	-	1,514	1,855	2,201	1,951	2,153
Goodwill	-	5,275	5,275	5,275	5,275	5,275
Other Intangible Assets	-	342.7	442.3	945.5	1,449	1,999
Long-Term Deferred Tax Assets	-	539.4	976.7	469.8	134.6	6.2
Other Long-Term Assets	-	6,922	6,208	6,496	4,757	3,820
Total Assets	-	42,288	40,007	39,005	32,659	44,054
Accounts Payable	-	1,662	2,171	2,639	2,837	4,268
Accrued Expenses	-	559.3	1,258	960.3	985.1	840.4
Short-Term Debt	-	-	-	-	58.2	-
Current Portion of Long-Term Debt	-	25	25	25	25	25
Current Portion of Leases	-	376.9	386.5	367.5	607.3	367.5
Current Income Taxes Payable	-	1,601	1,608	1,695	460	460
Current Unearned Revenue	-	566.3	34.8	1,795	1,806	1,823
Other Current Liabilities	-	675.3	1,090	1,048	964.9	949.5
Total Current Liabilities	-	5,466	6,574	8,529	7,743	8,734
Long-Term Leases	-	543.5	933.2	1,277	426.8	886.8
Other Long-Term Liabilities	-	323.3	427.6	498.6	453.7	382.9
Total Liabilities	-	6,332	7,934	10,361	8,729	10,099
Common Stock	-	457.5	457.5	457.5	457.5	457.5
Additional Paid-In Capital	-	13,207	13,207	13,207	13,207	13,207
Retained Earnings	-	21,303	17,620	14,354	9,830	19,950
Comprensive Income & Other	-	988.1	789.1	626	436.7	340.7
Shareholders' Equity	35,955	35,955	32,073	28,644	23,930	33,955
Total Liabilities & Equity	-	42,288	40,007	39,005	32,659	44,054
Total Debt	945.4	945.4	1,345	1,670	1,117	1,279
Net Cash (Debt)	19,522	19,327	17,139	14,663	9,947	20,669
Net Cash Growth	13.90%	12.77%	16.89%	47.41%	-51.87%	9.40%
Net Cash Per Share	426.72	422.45	374.62	320.49	217.42	451.77
Filing Date Shares Outstanding	45.75	45.75	45.75	45.75	45.75	45.75
Total Common Shares Outstanding	45.75	45.75	45.75	45.75	45.75	45.75
Working Capital	-	22,230	18,677	15,086	11,341	21,749
Book Value Per Share	785.76	785.95	701.08	626.13	523.09	742.22
Tangible Book Value	30,338	30,338	26,356	22,424	17,207	26,681
Tangible Book Value Per Share	663.00	663.15	576.11	490.16	376.12	583.22
Land	-	-	-	-	-	200
Buildings	-	132.6	125	125	124.7	124.7
Machinery	-	1,022	839.4	761.3	845.4	755.4
Construction In Progress	-	4	79.3	11.5	27.6	7.6
Leasehold Improvements	-	252.4	307.6	307.7	293.6	299.4

Source: S&P Capital IQ. Standard template. Financial Sources.